Journal of the American Academy of Child & Adolescent Psychiatry
Volume 47, Issue 1 , Pages 21-31 , January 2008

Misuse and Diversion of Stimulants Prescribed for ADHD: A Systematic Review of the Literature

,Accepted 30 August 2007.

REFERENCES 

  1. Faraone SV , Sergeant J , Gillberg C , et al.   The worldwide prevalence of ADHD: is it an American condition? . World Psychiatry . 2003;2:104–113
  2. Kessler RC , Adler L , Barkley R , et al.   The prevalence and correlates of adult ADHD in the United States: results from the national comorbidity survey replication . Am J Psychiatry . 2006;163:716–723
  3. Polanczyk G , de Lima MS , Horta BL , et al.   The worldwide prevalence of ADHD: a systematic review and metaregression analysis . Am J Psychiatry . 2007;164:942–948
  4. Goldman L , Genel M , Bezman RJ , et al.   Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents . JAMA . 1998;279:1100–1107
  5. Abikoff H , Hechtman L , Klein RG , et al.   Symptomatic improvement in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment . J Am Acad Child Adolesc Psychiatry . 2004;43:802–811
  6. MTA Cooperative Group  . Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: the multimodal treatment study of children with attention-deficit/hyperactivity disorder . Arch Gen Psychiatry . 1999;56:1088–1096
  7. MTA Cooperative Group  . A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD . Arch Gen Psychiatry . 1999;56:1073–1086
  8. Pliszka S . Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder . J Am Acad Child Adolesc Psychiatry . 2007;46:894–921
  9. Zametkin A , Ernst M . Problems in the management of attention-deficit-hyperactivity disorder . N Engl J Med . 1999;340:40–46
  10. Wilens TE , Spencer T . The stimulants revisited . Child Adolesc Psychiatr Clin N Am . 2000;9:573–603
  11. Greenhill LL , Pliszka S , Dulcan MK , et al.   Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults . J Am Acad Child Adolesc Psychiatry . 2002;41:26S–49S
  12. Barkley RA . A review of stimulant drug research with hyperactive children . J Child Psychol Psychiatry . 1977;18:137–165
  13. Greenhill L , Osman B . Ritalin: Theory and Practice . New York: Mary Ann Liebert Inc; 1999;
  14. Gillberg C , Melander H , Knorring A , et al.   Long-term stimulant treatment of children with attention-deficit hyperactivity disorder symptoms: a randomized, double-blind, placebo controlled trial . Arch Gen Psychiatry . 1997;54:857–864
  15. Anonymous  . Mental health in the United States. Prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder-United States, 2003 . MMWR Morbid Mortal Wkly Rep . 2005;54:842–847
  16. Vitiello B . Long-term effects of stimulant medications on the brain: possible relevance to the treatment of attention deficit hyperactivity disorder . J Child Adolesc Psychopharmacol . 2001;11:25–34
  17. Kollins SH , MacDonald EK , Cush CR . Assessing the abuse potential of methylphenidate in nonhuman and human subjects: a review . Pharmacol Biochem Behav . 2001;68:611–627
  18. Jasinski DR, Faries D, Allen AJ. Abuse liability assessment of atomoxetine in a drug-abusing population. In: Scientific Proceedings of the American Psychiatric Association; New York; May 1-6, 2004.
  19. National Institute on Drug Abuse  . Prescription Pain and Other Medications . http://www.drugabuse.gov/infofacts/PainMed.html 2006; Available at, Accessed July 18, 2006
  20. Teter CJ , McCabe SE , Boyd CJ , et al.   Illicit methylphenidate use in an undergraduate student sample: prevalence and risk factors . Pharmacotherapy . 2003;23:609–617
  21. McCabe SE , Teter CJ , Boyd CJ . The use, misuse and diversion of prescription stimulants among middle and high school students . Subst Use Misuse . 2004;39:1095–1116
  22. McCabe SE , Teter CJ , Boyd CJ . Medical use, illicit use, and diversion of abusable prescription drugs . J Am Coll Health . 2006;54:269–278
  23. Poulin C . From attention-deficit/hyperactivity disorder to medical stimulant use to the diversion of prescribed stimulants to non-medical stimulant use: connecting the dots . Addiction . 2007;102:740–751
  24. American Psychiatric Association  . Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV) . Washington, DC: American Psychiatric Association; 1994;
  25. Poulin C . Medical and nonmedical stimulant use among adolescents: from sanctioned to unsanctioned use . Can Med Assoc J . 2001;165:1039–1044
  26. Klein-Schwartz W , McGrath J . Poison centers' experience with methylphenidate abuse in pre-teens and adolescents . J Am Acad Child Adolesc Psychiatry . 2003;42:288–294
  27. Marsh LD , Kay JD , Payne TP . Methylphenidate misuse in substance abusing adolescents . J Child Adolesc Subst Abuse . 2000;9:1–14
  28. McCabe SE , Boyd CJ . Sources of prescription drugs for illicit use . Addict Behav . 2005;30:1342–1350
  29. McCabe SE , Knight JR , Teter CJ , et al.   Non-medical use of prescription stimulants among us college students: prevalence and correlates from a national survey . Addiction . 2005;99:96–106
  30. Babcock Q , Byrne T . Student perceptions of methylphenidate abuse at a public liberal arts college . J Am Coll Health . 2000;49:143–145
  31. Low KG , Gendaszek AE . Illicit use of psychostimulants among college students: a preliminary study . Psychol Health Med . 2002;7:283–287
  32. Barrett SP , Darredeau C , Bordy LE , et al.   Characteristics of methylphenidate misuse in a university student sample . Can J Psychiatry . 2005;50:457–461
  33. White BP , Becker-Blease KA , Grace-Bishop K . Stimulant medication use, misuse, and abuse in an undergraduate and graduate student sample . J Am Coll Health . 2006;54:261–268
  34. Kroutil LA , Van Brunt DL , Herman-Stahl MA , et al.   Nonmedical use of prescription stimulants in the United States . Drug Alcohol Depend . 2006;84:135–143
  35. Musser CJ , Ahmann PA , Theye FW , et al.   Stimulant use and potential for abuse in Wisconsin as reported by school administrators and longitudinally followed children . J Dev Behav Pediatr . 1998;19:187–192
  36. Wilens T , Gignac M , Swezey A , et al.   Characteristics of adolescents and young adults with ADHD who divert or misuse their prescribed medications . J Am Acad Child Adolesc Psychiatry . 2006;45:408–414
  37. Upadhyaya HP , Rose K , Wang W , et al.   Attention deficit hyperactivity disorder, medication treatment, and substance use patterns among adolescents and young adults . J Child Adolesc Psychopharmacol . 2005;15:799–809
  38. Teter CJ , McCabe SE , Cranford JA , et al.   Prevalence and motives for illicit use of prescription stimulants in an undergraduate student sample . J Am Coll Health . 2005;53:253–262
  39. Wu LT , Schlenger WE . Psychostimulant dependence in a community sample . Subst Use Misuse . 2003;38:221–248
  40. Hall KM , Irwin MM , Bowman KA , et al.   Illicit use of prescribed stimulant medication among college students . J Am Coll Health . 2005;53:167–174
  41. Teter CJ , McCabe SE , LaGrange K , et al.   Illicit use of specific prescription stimulants among college students: prevalence, motives, and routes of administration . Pharmacotherapy . 2006;26:1501–1510
  42. Bright GM, Delphia B, Wildberger B. Survey evaluation of the abuse potential of prescription stimulants among patients with ADHD. Presented at the 160th Annual Meeting of the American Psychiatric Association; San Diego; May 19-24, 2007.
  43. Mannuzza S , Klein RG , Bessler A , et al.   Adult outcome of hyperactive boys: educational achievement, occupational rank, and psychiatric status . Arch Gen Psychiatry . 1993;50:565–576
  44. Jaffe SL . Intranasal abuse of prescribed methylphenidate by an alcohol and drug abusing adolescent with ADHD . J Am Acad Child Adolesc Psychiatry . 1991;30:773–775
  45. Garland JE . Intranasal abuse of prescribed methylphenidate . J Am Acad Child Adolesc Psychiatry . 1998;37:573–574
  46. Drug Enforcement Administration  . Methylphenidate Review Document . Washington, DC: Office of Diversion Control, Drug and Chemical Evaluation Section; 1995;
  47. Volkow ND , Swanson JM . Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD . Am J Psychiatry . 2003;160:1909–1918
  48. Parasrampuria D, Schoedel K, Schuller R, et al Abuse potential of Oros methylphenidate versus immediate-release methylphenidate and placebo. Presented at the American Academy of Child and Adolescent Psychiatry/Canadian Academy of Child and Adolescent Psychiatry Joint Annual Meeting, Toronto; 2005.
  49. Spencer T , Biederman J , Ciccone P , et al.   A pet study examining pharmacokinetics, detection and likeability, and dopamine transporter receptor occupancy of short and long-acting orally administered formulations of methylphenidate in adults . Am J Psychiatry . 2006;163:387–395
  50. Jasinski J. Abuse liability studies of lisdexamfetamine dimesylate (NRP104). Presented at the 68th Annual Meeting of the College on Problems of Drug Dependence; Scottsdale, AZ; June 17-22, 2006.
  51. Jasinski DR . An evaluation of the abuse potential of modafinil using methylphenidate as a reference . J Psychopharmacol . 2000;14:53–60
  52. Stoops WW , Glaser PE , Rush CR . Reinforcing, subject-rated, and physiological effects of intranasal methylphenidate in humans: a dose-response analysis . Drug Alcohol Depend . 2003;71:179–186
  53. Markowitz JS , Straughn AB , Patrick KS . Advances in the pharmacotherapy of attention-deficit-hyperactivity disorder: focus on methylphenidate formulations . Pharmacotherapy . 2003;23:1281–1299
  54. Volkow ND , Ding Y , Fowler JS , et al.   Is methylphenidate like cocaine? Studies on the pharmacokinetics and distribution in the human brain . Arch Gen Psychiatry . 1995;52:456–463
  55. Volkow N , Wang G , Fowler J , et al.   Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate . Am J Psychiatry . 1998;155:1325–1331
  56. Volkow ND , Wang GJ , Fowler JS , et al.   Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications . Synapse . 2002;43:181–187

 This study was funded by grants from the National Institute of Drug Abuse U10 DA15831 and U10 DA13046 , (Dr. Roger Weiss, PI); R01 DA012945 and K24 DA016264 (Dr. Timothy Wilens, PI).

 Disclosure: Dr. Wilens has received research support from, has been a speaker for and served on the advisory boards of Abbott, Ortho-McNeil, Eli Lilly, GlaxoSmithKline, Merck, National Institute on Drug Abuse, Neurosearch, Novartis, Pfizer, and Shire. Dr. Adler receives and has received research support from, is and has been a speaker for, or is and has been on the advisory boards of Abbott, Bristol-Myers Squibb, Cephalon, Cortex, Eli Lilly, National Institute of Drug Abuse, Neurosearch, Novartis, McNeil/J & J, Merck, Organon, Pfizer, and Shire. The other authors report no conflicts of interest.

PII: S0890-8567(09)62081-5

doi: 10.1097/chi.0b013e31815a56f1

Journal of the American Academy of Child & Adolescent Psychiatry
Volume 47, Issue 1 , Pages 21-31 , January 2008

Article Tools